Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

American Healthcare REIT (AHR) EBITDA Margin (2016 - 2026)

American Healthcare REIT filings provide 10 years of EBITDA Margin readings, the most recent being 1.5% for Q4 2025.

  • On a quarterly basis, EBITDA Margin rose 662.0% to 1.5% in Q4 2025 year-over-year; TTM through Dec 2025 was 3.15%, a 499.0% increase, with the full-year FY2025 number at 3.15%, up 498.0% from a year prior.
  • EBITDA Margin hit 1.5% in Q4 2025 for American Healthcare REIT, down from 10.62% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 10.62% in Q3 2025 to a low of 12.26% in Q4 2022.
  • Median EBITDA Margin over the past 5 years was 2.17% (2021), compared with a mean of 2.35%.
  • Biggest five-year swings in EBITDA Margin: soared 15781bps in 2021 and later tumbled -596bps in 2022.
  • American Healthcare REIT's EBITDA Margin stood at 6.3% in 2021, then plummeted by -95bps to 12.26% in 2022, then soared by 52bps to 5.85% in 2023, then grew by 12bps to 5.12% in 2024, then skyrocketed by 129bps to 1.5% in 2025.
  • The last three reported values for EBITDA Margin were 1.5% (Q4 2025), 10.62% (Q3 2025), and 2.08% (Q2 2025) per Business Quant data.